Literature DB >> 17904748

A randomized trial comparing ReCell system of epidermal cells delivery versus classic skin grafts for the treatment of deep partial thickness burns.

G Gravante1, M C Di Fede, A Araco, M Grimaldi, B De Angelis, A Arpino, V Cervelli, A Montone.   

Abstract

BACKGROUND: Our purpose was to directly compare results obtained with the ReCell system and the classic skin grafting for epidermal replacement in deep partial thickness burns.
MATERIALS AND METHODS: We recruited all patients with deep partial thickness burns admitted at the Burn Centre of S. Eugenio Hospital in Rome over 2 years. Enrollment was conducted with a controlled strategy--sampling chart--that allowed homogeneous groups (ReCell and skin grafting) for age, gender, type of burns and total burn surface area (TBSA). We evaluated as primary endpoints of the study the (i) time for complete epithelization (both treated area and biopsy site) and (ii) aesthetic and functional quality of the epithelization (color, joint contractures). Secondary endpoints were the assessment of infections, inflammations or any adverse effects of the ReCell procedure, particular medications assumed, postoperative pain.
RESULTS: Eighty-two patients were analyzed in two homogeneous groups. All of them received adequate epidermal replacement, but skin grafting was faster than ReCell (p<0.05). On the contrary, ReCell biopsy areas and postoperative pain were smaller than classic grafting (p<0.05). The aesthetic and functional outcomes were similar between procedures.
CONCLUSIONS: ReCell is a feasible, simple and safe technique. It gives similar results to skin grafting but, harvesting minor areas, can open possible future applications in the management of large-burns patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17904748     DOI: 10.1016/j.burns.2007.04.011

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  45 in total

1.  Combination of medical needling and non-cultured autologous skin cell transplantation (renovacell) for repigmentation of hypopigmented burn scars in children and young people.

Authors:  K H Busch; R Bender; N Walezko; H Aziz; M A Altintas; M C Aust
Journal:  Ann Burns Fire Disasters       Date:  2016-06-30

Review 2.  New technologies in global burn care - a review of recent advances.

Authors:  Laura Kearney; Eamon C Francis; Anthony Jp Clover
Journal:  Int J Burns Trauma       Date:  2018-08-20

Review 3.  [Surgical treatment of burns : Special aspects of pediatric burns].

Authors:  G Bührer; J P Beier; R E Horch; A Arkudas
Journal:  Hautarzt       Date:  2017-05       Impact factor: 0.751

Review 4.  Concise review: clinical translation of wound healing therapies based on mesenchymal stem cells.

Authors:  Wesley M Jackson; Leon J Nesti; Rocky S Tuan
Journal:  Stem Cells Transl Med       Date:  2011-12-07       Impact factor: 6.940

5.  Combined use of hyperbaric oxygen and sprayed keratinocyte suspension to tackle a difficult wound.

Authors:  P C Jackson; D Wilks; J Rawlins; P L Matteucci
Journal:  Ann R Coll Surg Engl       Date:  2014-09       Impact factor: 1.891

6.  Clinical Evaluation of NIKS-Based Bioengineered Skin Substitute Tissue in Complex Skin Defects: Phase I/IIa Clinical Trial Results.

Authors:  Michael J Schurr; Kevin N Foster; Mary A Lokuta; Cathy A Rasmussen; Christina L Thomas-Virnig; Lee D Faucher; Daniel M Caruso; B Lynn Allen-Hoffmann
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-04       Impact factor: 4.730

Review 7.  Hypertrophic scarring: the greatest unmet challenge after burn injury.

Authors:  Celeste C Finnerty; Marc G Jeschke; Ludwik K Branski; Juan P Barret; Peter Dziewulski; David N Herndon
Journal:  Lancet       Date:  2016-10-01       Impact factor: 79.321

Review 8.  Bioprinting: From Tissue and Organ Development to in Vitro Models.

Authors:  Carlos Mota; Sandra Camarero-Espinosa; Matthew B Baker; Paul Wieringa; Lorenzo Moroni
Journal:  Chem Rev       Date:  2020-05-14       Impact factor: 60.622

9.  The use of a non cultured autologous cell suspension to repair chronic ulcers.

Authors:  B De Angelis; A Migner; L Lucarini; A Agovino; V Cervelli
Journal:  Int Wound J       Date:  2013-02-28       Impact factor: 3.315

10.  Nanofibrous polycaprolactone scaffolds with adhered platelets stimulate proliferation of skin cells.

Authors:  K Vocetkova; M Buzgo; V Sovkova; D Bezdekova; P Kneppo; E Amler
Journal:  Cell Prolif       Date:  2016-07-24       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.